Horizon Technologies


The goal of the Horizon Technologies Working Group is to nurture and identify emerging diagnostic technologies that have the potential to impact the current COVID pandemic, and to help accelerate their deployment.

We will work with researchers to help them better understand current unmet needs so they can better target their efforts. In addition, we will evaluate the most promising new technologies, and help connect their developers with the resources needed to translate this work to have a real world impact (e.g. through validation, scaling, etc.). There is a tremendous amount of creativity and energy in our research community, and we are excited to help funnel this into solutions that will have an impact on the current crisis.

Download the Diagnostic Playbook: Focus on COVID-19 Use Cases

Download the Diagnostic Playbook: Translation from the Lab


Improve public health by enabling the next generation of diagnostic technologies to reach patients.


Serve as the bridge between tech developers and clinical use.​



Determine unmet clinical needs and opportunities for innovation.


Identify and evaluate promising emerging technological solutions to unmet needs.


Engage with technology developers to help accelerate their path to the clinic.


Wesley P. Wong, Ph.D.
Lead, Horizon Technologies

Lauren Linton, Ph.D.
Lead, Opportunities & Evaluation Subgroups

Jessica McDonough, Ph.D.
Lead, Engagement Subgroup

James A. Toombs, Ph.D.
Project Manager

Sara Yohannes
Administrative Lead

For more information or if you have other questions, please email covid_innovation_diagnostics@PARTNERS.ORG